| Product Code: ETC13149382 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Neuroimaging Market was valued at USD 5 Billion in 2024 and is expected to reach USD 7 Billion by 2031, growing at a compound annual growth rate of 5.20% during the forecast period (2025-2031).
The Global Neuroimaging Market is witnessing significant growth due to the rising prevalence of neurological disorders and the increasing demand for early and accurate diagnosis. Advances in technology, such as functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), have improved imaging resolution and diagnostic capabilities. The market is driven by the growing adoption of neuroimaging techniques in research and clinical settings, as well as the expanding applications in fields like neurology, psychiatry, and oncology. Moreover, the rising investment in healthcare infrastructure and the development of innovative imaging solutions are fueling market growth. Key players in the global neuroimaging market include Siemens Healthineers, GE Healthcare, and Philips Healthcare, among others. The market is projected to continue expanding as new technologies and applications emerge, catering to the increasing demand for advanced neuroimaging solutions worldwide.
The Global Neuroimaging Market is witnessing significant growth driven by technological advancements, increasing prevalence of neurological disorders, and rising investments in research and development. Key trends include the adoption of advanced imaging techniques such as functional magnetic resonance imaging (fMRI) and positron emission tomography (PET) for better diagnosis and treatment planning. There is a growing focus on personalized medicine and precision healthcare, leading to the integration of neuroimaging with artificial intelligence and machine learning algorithms for more accurate analyses. Opportunities lie in expanding applications of neuroimaging beyond clinical diagnostics to areas like drug development, neurology research, and mental health monitoring. With the increasing demand for non-invasive and early disease detection methods, the neuroimaging market is poised for further expansion in the coming years.
The Global Neuroimaging Market faces several challenges, including high costs associated with advanced imaging technologies, limited access to specialized equipment in certain regions, and the complexity of interpreting neuroimaging data accurately. Additionally, regulatory hurdles, such as data privacy concerns and compliance with strict imaging protocols, can hinder the market`s growth. Furthermore, the shortage of skilled professionals trained in neuroimaging techniques poses a significant challenge for healthcare providers looking to incorporate advanced imaging technologies into their practices. Addressing these challenges will require continued innovation in imaging technology, increased investment in training programs, and collaboration between stakeholders to improve access and affordability of neuroimaging services worldwide.
The global neuroimaging market is primarily driven by the increasing prevalence of neurological disorders and brain injuries, as well as the growing demand for early and accurate diagnosis of such conditions. Technological advancements in neuroimaging techniques, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET), are also fueling market growth. Additionally, the rising investments in research and development activities focused on improving neuroimaging technologies and expanding applications in areas like neurology, psychiatry, and oncology are further propelling market expansion. The increasing adoption of advanced imaging modalities in healthcare facilities, coupled with the growing awareness about the benefits of early detection and treatment of neurological diseases, are expected to continue driving the growth of the global neuroimaging market in the foreseeable future.
Government policies related to the Global Neuroimaging Market vary by country but generally focus on regulating the use and application of neuroimaging technologies for medical purposes. These policies often include guidelines for the ethical use of neuroimaging data, standards for equipment calibration and certification, and requirements for training and certification of healthcare professionals performing neuroimaging procedures. Additionally, governments may provide funding or incentives to support research and development in neuroimaging technologies, as well as initiatives to increase access to neuroimaging services for patients. Regulatory bodies such as the FDA in the United States and the European Medicines Agency in the EU play a key role in overseeing the approval and monitoring of neuroimaging products and technologies to ensure safety and efficacy in clinical settings.
The Global Neuroimaging Market is expected to witness significant growth in the coming years, driven by advancements in technology, increasing prevalence of neurological disorders, and growing investments in healthcare infrastructure. The rise in geriatric population, who are more prone to neurological conditions, also contributes to the market expansion. Additionally, the adoption of artificial intelligence and machine learning in neuroimaging techniques is enhancing diagnostic accuracy and treatment planning, further boosting market growth. The market is anticipated to see a surge in demand for neuroimaging devices and services, particularly in regions with a high burden of neurological diseases. However, challenges related to high costs and limited accessibility in some regions may hinder the market`s full potential. Overall, the Global Neuroimaging Market is poised for a promising future with continued technological innovations and increasing healthcare investments.
In the global neuroimaging market, North America holds a significant market share due to the presence of advanced healthcare infrastructure, increasing prevalence of neurological disorders, and high adoption of innovative imaging technologies. Europe follows closely behind, driven by growing research and development activities in the field of neuroimaging and rising investments in healthcare. Asia-Pacific is expected to witness the fastest growth, attributed to improving healthcare facilities, rising awareness about neurological conditions, and increasing government initiatives for better healthcare access. The Middle East and Africa region is also showing promising growth opportunities driven by the expanding healthcare infrastructure and increasing focus on early disease diagnosis. Latin America is experiencing steady growth, supported by a growing patient population and increasing healthcare expenditure in the region.
Global Neuroimaging Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Neuroimaging Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Neuroimaging Market Revenues & Volume, 2021 & 2031F |
3.3 Global Neuroimaging Market - Industry Life Cycle |
3.4 Global Neuroimaging Market - Porter's Five Forces |
3.5 Global Neuroimaging Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Neuroimaging Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Global Neuroimaging Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Neuroimaging Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Neuroimaging Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Neuroimaging Market Trends |
6 Global Neuroimaging Market, 2021 - 2031 |
6.1 Global Neuroimaging Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Neuroimaging Market, Revenues & Volume, By Magnetic Resonance Imaging (MRI), 2021 - 2031 |
6.1.3 Global Neuroimaging Market, Revenues & Volume, By Computed Tomography (CT), 2021 - 2031 |
6.1.4 Global Neuroimaging Market, Revenues & Volume, By Positron Emission Tomography (PET), 2021 - 2031 |
6.1.5 Global Neuroimaging Market, Revenues & Volume, By Single Photon Emission Computed Tomography (SPECT), 2021 - 2031 |
6.1.6 Global Neuroimaging Market, Revenues & Volume, By Functional Magnetic Resonance Imaging (fMRI), 2021 - 2031 |
6.1.7 Global Neuroimaging Market, Revenues & Volume, By Diffusion Tensor Imaging (DTI), 2021 - 2031 |
6.1.8 Global Neuroimaging Market, Revenues & Volume, By Magnetoencephalography (MEG), 2021 - 2031 |
6.1.9 Global Neuroimaging Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Neuroimaging Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Neuroimaging Market, Revenues & Volume, By Neurological Disorders, 2021 - 2031 |
6.2.3 Global Neuroimaging Market, Revenues & Volume, By Psychiatric Disorders, 2021 - 2031 |
6.2.4 Global Neuroimaging Market, Revenues & Volume, By Traumatic Brain Injury (TBI), 2021 - 2031 |
6.3 Global Neuroimaging Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Neuroimaging Market, Revenues & Volume, By Hospitals and Clinics, 2021 - 2031 |
6.3.3 Global Neuroimaging Market, Revenues & Volume, By Diagnostic Centers, 2021 - 2031 |
6.3.4 Global Neuroimaging Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
6.3.5 Global Neuroimaging Market, Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031 |
6.3.6 Global Neuroimaging Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Neuroimaging Market, Overview & Analysis |
7.1 North America Neuroimaging Market Revenues & Volume, 2021 - 2031 |
7.2 North America Neuroimaging Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Neuroimaging Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4 North America Neuroimaging Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Neuroimaging Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Neuroimaging Market, Overview & Analysis |
8.1 Latin America (LATAM) Neuroimaging Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Neuroimaging Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Neuroimaging Market, Revenues & Volume, By Technology, 2021 - 2031 |
8.4 Latin America (LATAM) Neuroimaging Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Neuroimaging Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Neuroimaging Market, Overview & Analysis |
9.1 Asia Neuroimaging Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Neuroimaging Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Neuroimaging Market, Revenues & Volume, By Technology, 2021 - 2031 |
9.4 Asia Neuroimaging Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Neuroimaging Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Neuroimaging Market, Overview & Analysis |
10.1 Africa Neuroimaging Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Neuroimaging Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Neuroimaging Market, Revenues & Volume, By Technology, 2021 - 2031 |
10.4 Africa Neuroimaging Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Neuroimaging Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Neuroimaging Market, Overview & Analysis |
11.1 Europe Neuroimaging Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Neuroimaging Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Neuroimaging Market, Revenues & Volume, By Technology, 2021 - 2031 |
11.4 Europe Neuroimaging Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Neuroimaging Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Neuroimaging Market, Overview & Analysis |
12.1 Middle East Neuroimaging Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Neuroimaging Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Neuroimaging Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Neuroimaging Market, Revenues & Volume, By Technology, 2021 - 2031 |
12.4 Middle East Neuroimaging Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Neuroimaging Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Neuroimaging Market Key Performance Indicators |
14 Global Neuroimaging Market - Export/Import By Countries Assessment |
15 Global Neuroimaging Market - Opportunity Assessment |
15.1 Global Neuroimaging Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Neuroimaging Market Opportunity Assessment, By Technology, 2021 & 2031F |
15.3 Global Neuroimaging Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Neuroimaging Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Neuroimaging Market - Competitive Landscape |
16.1 Global Neuroimaging Market Revenue Share, By Companies, 2024 |
16.2 Global Neuroimaging Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here